Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COVID-19 Antibody and Reinfection Study

NCT05365750 is registered in ClinicalTrials.gov with Kaiser Permanente as lead sponsor.

NCT NCT05365750
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05365750 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COVID-19 Antibody and Reinfection Study
Lead sponsor
Kaiser Permanente
Phase
Observational
Overall status
Completed
Start date
June 15, 2020
Completion date
December 31, 2024
Enrollment
4,235 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 testing